IL10 and acute respiratory distress syndrome: Decreased IL-10 has been reported in clinical specimens such as plasma and BALF from ARDS patients [17], and the treatment of ALI mice with recombinant IL-10/Fc [18] or an IL-10 stimulator molecule S100A8 has been associated with decreased lung inflammation and lung injury [19,20].